Table of contents

J. Am. Coll. Cardiol. 2005;45;1316

doi:10.1016/j.jacc.2005.02.003

This information is current as of March 5, 2010

The online version of this article, along with updated information and services, is
located on the World Wide Web at:
http://content.onlinejacc.org

Downloaded from content.onlinejacc.org by on March 5, 2010

Journal of the American College of Cardiology

2005 by the American College of Cardiology Foundation
Published by Elsevier Inc.

Vol. 45, No. 8, 2005

ISSN 0735-1097/05/$30.00
doi:10.1016/j.jacc.2005.02.003

Table of Contents
Preamble .................................................................................1317
Introduction: Eligibility Recommendations for
Competitive Athletes With Cardiovascular Abnormalities
General Considerations.........................................................1318
Impetus for the Revision ...................................................1318
Definitions .........................................................................1318
Prevalence...........................................................................1318
Conference Design and Format ........................................1319
Recommendations for Disqualification and Eligibility .....1319
Special Considerations .......................................................1320
References ..........................................................................1321
Appendix 1.........................................................................1321
Task Force 1: Preparticipation Screening and Diagnosis
of Cardiovascular Disease in Athletes .................................1322
Preparticipation Screening .................................................1322
Diagnostic Testing Strategies ............................................1323
Athletes Heart and Cardiovascular Disease .....................1324
References ..........................................................................1325
Appendix 1.........................................................................1326
Task Force 2: Congenital Heart Disease ............................1326
General Considerations .....................................................1326
Types of Congenital Defects .............................................1326
References ..........................................................................1333
Appendix 1.........................................................................1333
Task Force 3: Valvular Heart Disease.................................1334
General Considerations .....................................................1334
Mitral Stenosis ...................................................................1334
Mitral Regurgitation ..........................................................1335
Aortic Stenosis ...................................................................1336
Aortic Regurgitation ..........................................................1337
Bicuspid Aortic Valves With Aortic Root Dilatation .........1338
Tricuspid Regurgitation.....................................................1338
Tricuspid Stenosis..............................................................1338
Multivalvular Disease.........................................................1338
Prosthetic Heart Valves .....................................................1338
Valve Repair or Percutaneous Mitral Balloon
Valvotomy .....................................................................1339
References ..........................................................................1339
Appendix 1.........................................................................1340
Task Force 4: HCM and Other Cardiomyopathies, Mitral
Valve Prolapse, Myocarditis, and Marfan Syndrome.........1340
Hypertrophic Cardiomyopathy ..........................................1340
Mitral Valve Prolapse (MVP) ...........................................1341
Myocarditis ........................................................................1342
Marfan Syndrome ..............................................................1342
Ehlers-Danlos Syndrome...................................................1343
Arrhythmogenic Right Ventricular Cardiomyopathy
(ARVC) ........................................................................1343
Other Myocardial Diseases................................................1343
Pericarditis..........................................................................1344
References ..........................................................................1344
Appendix 1.........................................................................1345

Task Force 5: Systemic Hypertension .................................1346

General Considerations .....................................................1346
References ..........................................................................1347
Appendix 1.........................................................................1348
Task Force 6: Coronary Artery Disease ..............................1348
Atherosclerotic Coronary Artery Disease..........................1348
Coronary Artery Vasospasm ..............................................1351
CAD in Cardiac Transplant Recipients............................1351
Myocardial Bridging ..........................................................1352
References ..........................................................................1352
Appendix 1.........................................................................1353
Task Force 7: Arrhythmias ...................................................1354
General Considerations .....................................................1354
Syncope ..............................................................................1355
Types of Arrhythmias ........................................................1356
References ..........................................................................1362
Appendix 1.........................................................................1363
Task Force 8: Classification of Sports.................................1364
Response and Adaptation to Exercise ...............................1364
Athletes Heart...................................................................1365
Classification of Sports ......................................................1365
Limitations of Classification..............................................1366
References ..........................................................................1367
Appendix 1.........................................................................1367
Task Force 9: Drugs and Performance-Enhancing
Substances ..............................................................................1368
General Considerations .....................................................1368
References ..........................................................................1369
Appendix 1.........................................................................1369
Task Force 10: Automated External Defibrillators ............1369
General Considerations of Cardiac Arrest Risk
Among Athletes ...........................................................1369
Role of Automated External Defibrillators in
Response to Cardiac Arrest..........................................1370
AEDs at Sites of Training and Competition ...................1370
References ..........................................................................1370
Appendix 1.........................................................................1371
Task Force 11: Commotio Cordis ......................................1371
General Considerations .....................................................1371
References ..........................................................................1373
Appendix 1.........................................................................1373
Task Force 12: Legal Aspects of the 36th Bethesda
Conference Recommendations ............................................1373
General Considerations .....................................................1373
References ..........................................................................1375
Appendix 1.........................................................................1375

Downloaded from content.onlinejacc.org by on March 5, 2010

Table of contents
J. Am. Coll. Cardiol. 2005;45;1316
doi:10.1016/j.jacc.2005.02.003
This information is current as of March 5, 2010
Rights & Permissions

Information about reproducing this article in parts (figures,

tables) or in its entirety can be found online at:
http://content.onlinejacc.org/misc/permissions.dtl

Reprints

Information about ordering reprints can be found online:

http://content.onlinejacc.org/misc/reprints.dtl

Downloaded from content.onlinejacc.org by on March 5, 2010